Actavis Blasts USPTO Decision In Opana Row
Actavis Inc. on Tuesday asked a New York federal judge overseeing Endo Pharmaceuticals Inc.'s case accusing it and several other generics manufacturers of infringing its patent for painkiller Opana ER to...To view the full article, register now.
Already a subscriber? Click here to view full article